Scailyte - About the company
Scailyte is a series A company based in Lucerne (Switzerland), founded in 2017 by , , and . It operates as an Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery. Scailyte has raised $20.3M in funding from investors like Swisscom, Mirabaud and Venturelab. The company has 86 active competitors, including 29 funded and 17 that have exited. Its top competitors include companies like Metabolon, Maze Therapeutics and Seer.
Company Details
Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery. The company is developing AI software for single-cell data analysis to discover novel biomarkers for the early and precise detection of a wide range of complex diseases. This AI-based single-cell technology can also be used for the identification of relevant single-cell patterns from mass cytometry data.
- Website
- Social
Key Metrics
Founded Year
2017
Location
Lucerne, Switzerland
Stage
Series A
Total Funding
in 8 rounds
Latest Funding Round
Investors
Ranked
6th among 86 active competitors
Similar Companies
Get your free copy of Scailyte's company profile
Scailyte's funding and investors
Scailyte has raised a total funding of $20.3M over 8 rounds. Its first funding round was on Jul 30, 2017.
Scailyte has 9 institutional investors including Swisscom, Mirabaud and Venturelab.
Here is the list of recent funding rounds of Scailyte:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Dec 05, 2023 | $8M | Series A | 6747260 | 3453894 | - |
Sep 21, 2022 | $6.22M | Series A | 8949500 | 7914528 | |
Jan 10, 2022 | Undisclosed | Series A | 3014324 | 1268085 | - |
Access funding benchmarks and valuations. Sign up today!View details of Scailyte's funding rounds and investors
Scailyte's founders and board of directors
The founders of Scailyte are , , and . is the CEO of Scailyte.
View details of Scailyte's Founder profiles and Board Members
Scailyte's Competitors and alternates
Top competitors of Scailyte include Metabolon, Maze Therapeutics and Seer. Here is the list of Top 10 competitors of Scailyte, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Metabolon 2000, Morrisville (United States), Series H | Provider of solutions for biomarker discovery, diagnostic tests and personalized medicine | $181M | EW Healthcare Partners, Perceptive AdvisorsÌý&²¹³¾±è;Ìý | 73/100 |
2nd | Maze Therapeutics 2018, Redwood City (United States), Public | Developer of genetic bio-markers in neurological, metabolic, and renal diseases | $496M | Foresite Capital, Arch Venture PartnersÌý&²¹³¾±è;Ìý | 70/100 |
3rd | Seer 2017, San Francisco (United States), Public | Developer of proteomics platform for early detection of cancer and neurological diseases | $128M | T. Rowe Price, HBM Healthcare InvestmentsÌý&²¹³¾±è;Ìý | 67/100 |
4th | NeoPhore 2017, Cambridge (United Kingdom), Series B | Developer of small molecule therapies to treat cancer | $44.6M | Astellas Venture Management, ParkwalkÌý&²¹³¾±è;Ìý | 63/100 |
5th |  Alector 2013, San Francisco (United States), Public | Developing immuno-modulatory therapies for dementia and other neurodegenerative disorders | $215M | New Leaf Venture Partners, Foresite CapitalÌý&²¹³¾±è;Ìý | 70/100 |
6th | Scailyte 2017, Lucerne (Switzerland), Series A | Artificial intelligence (AI) based single-cell data analysis for novel biomarker discovery | $20.3M | Zurcher Kantonalbank, MassChallengeÌý&²¹³¾±è;Ìý | 54/100 |
7th | Lexicon Pharmaceuticals 1995, The Woodlands (United States), Public | Developer of small molecule drugs for diffrent health diseases | - | New Enterprise Associates, Bay City CapitalÌý&²¹³¾±è;Ìý | 60/100 |
8th |  Tango Therapeutics 2017, Cambridge (United States), Public | Developer of drugs for the treatment of cancer | $165M | Third Rock Ventures, Casdin CapitalÌý&²¹³¾±è;Ìý | 66/100 |
9th | Goldfinch 2016, Cambridge (United States), Deadpooled | Developer of precision therapies for the treatment of genetic kidney disease | $157M | Wellington, BlackRockÌý&²¹³¾±è;Ìý | 54/100 |
10th | Provider of a technology platform for the discovery of antibody-based drugs | $180M | Sequoia Capital, IDG CapitalÌý&²¹³¾±è;Ìý | 58/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Scailyte's competitors? Click to see the top ones
Scailyte's Investments and acquisitions
Scailyte has made no investments or acquisitions yet.
Reports related to Scailyte
Here is the latest report on Scailyte's sector:
View
News related to Scailyte
Media has covered Scailyte for a total of 3 events in the last 1 year, 2 of them have been about people movement and 1 about partnerships.
•
•
•
•
•
•
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Scailyte
When was Scailyte founded?
Scailyte was founded in 2017.Where is Scailyte located?
Scailyte is located in Lucerne, Switzerland.Is Scailyte a funded company?
Scailyte is a funded company, its first funding round was on Jul 30, 2017.When was the latest funding round of Scailyte?
Scailyte's latest funding round was on Dec 05, 2023.What is the annual revenue of Scailyte?
Annual revenue of Scailyte is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Imprint AI - Wilmington based, 2024 founded, Unfunded company
- A-i.onl - 2023 founded, Unfunded company
- Cloud9 Telehealth - Austin based, 2015 founded, Unfunded company
- Troxel Aerospace - Gainesville based, 2015 founded, Unfunded company
- Keyword Finder - Jupiter based, 2024 founded, Unfunded company
- Ethsoil - Public company
